Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04967209 · ClinicalTrials.gov registry record
Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
A clinical trial, sponsored by Noom.
- Completed
- Registry status
- 30
- Enrollment target
NCT04967209: Completed study, sponsored by Noom.
NCT04967209 is a clinical trial that has completed, run by Noom. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04967209 has completed, sponsored by Noom.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This mixed methods study will involve obtaining user feedback on the first 4 weeks of the Healthy Habits for Cancer (HCC) Program. Short pre and post surveys and in-depth qualitative interviews will be conducted exploring their views on the app (features they liked and didn't like), the extent to which they believe the app would have to be further adapted, how they would feel about such an app being embedded in their cancer care and when in their care pathway they would like to be offered it.
Primary Outcome
Self reported measure of multidimensional quality of life (QL) in patients with breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-07-05 |
| Est. Completion | 2021-08-12 |
What the finished NCT04967209 record still lists
NCT04967209 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04967209 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04967209 about?
NCT04967209 is a clinical study titled "Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer". This mixed methods study will involve obtaining user feedback on the first 4 weeks of the Healthy Habits for Cancer (HCC) Program. Short pre and post surveys and in-depth qualitative interviews will be conducted exploring their views on the app (features they liked and didn't like), the extent to wh...
What is the current status of trial NCT04967209?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-07-05. Estimated completion is 2021-08-12.
Who is sponsoring clinical trial NCT04967209?
This trial is sponsored by Noom, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI